Laura Silvian

2.3k total citations
31 papers, 1.4k citations indexed

About

Laura Silvian is a scholar working on Molecular Biology, Cell Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Laura Silvian has authored 31 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Cell Biology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Laura Silvian's work include Nerve injury and regeneration (4 papers), Microtubule and mitosis dynamics (3 papers) and Biochemical and Molecular Research (2 papers). Laura Silvian is often cited by papers focused on Nerve injury and regeneration (4 papers), Microtubule and mitosis dynamics (3 papers) and Biochemical and Molecular Research (2 papers). Laura Silvian collaborates with scholars based in United States, Switzerland and South Korea. Laura Silvian's co-authors include Thomas A. Steitz, Jimin Wang, Phuong Pham, Eric A. Toth, Myron F. Goodman, Barbro Beijer, Brian S. Sproat, Virginia L. Rath, Alexey A. Lugovskoy and Steven A. Berkowitz and has published in prestigious journals such as Science, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Laura Silvian

31 papers receiving 1.4k citations

Peers

Laura Silvian
Bainan Wu United States
Rob Ruijtenbeek Netherlands
Cecilia Chiu United States
Shehab Ismail United Kingdom
Christine Tam United States
Laura Silvian
Citations per year, relative to Laura Silvian Laura Silvian (= 1×) peers Ingrid Remy

Countries citing papers authored by Laura Silvian

Since Specialization
Citations

This map shows the geographic impact of Laura Silvian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Silvian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Silvian more than expected).

Fields of papers citing papers by Laura Silvian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Silvian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Silvian. The network helps show where Laura Silvian may publish in the future.

Co-authorship network of co-authors of Laura Silvian

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Silvian. A scholar is included among the top collaborators of Laura Silvian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Silvian. Laura Silvian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sauvé, Véronique, Eric Stefan, Nathalie Croteau, et al.. (2024). Activation of parkin by a molecular glue. Nature Communications. 15(1). 7707–7707. 17 indexed citations
2.
Silvian, Laura. (2022). PINK1/Parkin Pathway Activation for Mitochondrial Quality Control – Which Is the Best Molecular Target for Therapy?. Frontiers in Aging Neuroscience. 14. 890823–890823. 29 indexed citations
3.
Shlevkov, Evgeny, Paramasivam Murugan, Eric Stefan, et al.. (2021). Discovery of small-molecule positive allosteric modulators of Parkin E3 ligase. iScience. 25(1). 103650–103650. 19 indexed citations
4.
Marcotte, D.J., Yuting Liu, J. Howard Jones, et al.. (2016). Structural determinant for inducing RORgamma specific inverse agonism triggered by a synthetic benzoxazinone ligand. BMC Structural Biology. 16(1). 7–7. 23 indexed citations
5.
Ma, Bin, Murugan Paramasivam, Klaus Michelsen, et al.. (2016). ATP-Competitive MLKL Binders Have No Functional Impact on Necroptosis. PLoS ONE. 11(11). e0165983–e0165983. 31 indexed citations
6.
Enyedy, Istvan, Noel A. Powell, Justin A. Caravella, et al.. (2016). Discovery of biaryls as RORγ inverse agonists by using structure-based design. Bioorganic & Medicinal Chemistry Letters. 26(10). 2459–2463. 12 indexed citations
7.
Chao, Jianhua, Istvan Enyedy, D.J. Marcotte, et al.. (2015). Discovery of biaryl carboxylamides as potent RORγ inverse agonists. Bioorganic & Medicinal Chemistry Letters. 25(15). 2991–2997. 27 indexed citations
8.
Ishchenko, Alexey, Lin Zhang, Junhua Fan, et al.. (2014). Structure-based design of low-nanomolar PIM kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(3). 474–480. 17 indexed citations
9.
Tam, Betty Y., Cheryl Black, Deping Wang, et al.. (2012). Synthesis, SAR and biological evaluation of 1,6-disubstituted-1H-pyrazolo[3,4-d]pyrimidines as dual inhibitors of Aurora kinases and CDK1. Bioorganic & Medicinal Chemistry Letters. 22(5). 2070–2074. 35 indexed citations
10.
Marcotte, D.J., Yuting Liu, Robert M. Arduini, et al.. (2010). Structures of human Bruton's tyrosine kinase in active and inactive conformations suggest a mechanism of activation for TEC family kinases. Protein Science. 19(3). 429–439. 106 indexed citations
11.
Guckian, Kevin M., Edward Yin-Shiang Lin, Laura Silvian, et al.. (2008). Design and synthesis of a series of meta aniline-based LFA-1 ICAM inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(19). 5249–5251. 17 indexed citations
12.
Rushe, Mia, Laura Silvian, Sarah A. Bixler, et al.. (2008). Structure of a NEMO/IKK-Associating Domain Reveals Architecture of the Interaction Site. Structure. 16(5). 798–808. 109 indexed citations
13.
Lin, Edward Yin-Shiang, Kevin M. Guckian, Laura Silvian, et al.. (2008). Structure–activity relationship of ortho- and meta-phenol based LFA-1 ICAM inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(19). 5245–5248. 3 indexed citations
14.
Silvian, Laura, Ping Jin, Paul Carmillo, et al.. (2006). Artemin Crystal Structure Reveals Insights into Heparan Sulfate Binding. Biochemistry. 45(22). 6801–6812. 40 indexed citations
15.
Sah, Dinah W.Y., Michael H. Ossipov, Anthony Rossomando, Laura Silvian, & Frank Porreca. (2005). New Approaches for the Treatment of Pain: The GDNF Family of Neurotrophic Growth Factors. Current Topics in Medicinal Chemistry. 5(6). 577–583. 29 indexed citations
16.
Li, Weiwei, Lee Walus, Sylvia A. Rabacchi, et al.. (2004). A Neutralizing Anti-Nogo66 Receptor Monoclonal Antibody Reverses Inhibition of Neurite Outgrowth by Central Nervous System Myelin. Journal of Biological Chemistry. 279(42). 43780–43788. 47 indexed citations
17.
Fairclough, Robert H., et al.. (2003). Agonist‐Induced Transitions of the Acetylcholine Receptor. Annals of the New York Academy of Sciences. 998(1). 101–113. 2 indexed citations
18.
Silvian, Laura, et al.. (2001). Crystal structure of a DinB family error-prone DNA polymerase from Sulfolobus solfataricus.. Nature Structural Biology. 8(11). 984–989. 144 indexed citations
19.
Silvian, Laura, et al.. (1998). Distance between α‐Cys 192 of the Acetylcholine Receptor and Rhodamine‐labeled α‐Bungarotoxin Complexed to the Receptor. Annals of the New York Academy of Sciences. 841(1). 104–107. 1 indexed citations
20.
Rath, Virginia L., Laura Silvian, Barbro Beijer, Brian S. Sproat, & Thomas A. Steitz. (1998). How glutaminyl-tRNA synthetase selects glutamine. Structure. 6(4). 439–449. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026